Ckd Bio Capital Reinvestment Ratio
Ckd Bio capital reinvestment ratio. Ckd Bio (063160) has a Capital Reinvestment Ratio of 1.29x as of June 2026, meaning it reinvests 1% of its operating cash flow (₩2.62 Billion) in capital expenditures (₩3.37 Billion). Check Ckd Bio investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Ckd Bio (2008–2024)
Capital reinvestment ratio of Ckd Bio from 2008 to 2024. This chart tracks Ckd Bio's Capital Reinvestment Ratio across 14 annual periods. Also explore net asset momentum of Ckd Bio to track the company's year-over-year net asset growth rate.
Ckd Bio Capital Reinvestment Ratio by Year (2008–2024)
Ckd Bio capital reinvestment ratio by year from 2008 to 2024. For the full cash flow conversion analysis, see 063160 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.31x | ₩14.03 Billion | ₩4.28 Billion | ▼ -97.6% |
| 2020 | 12.78x | ₩4.82 Billion | ₩61.66 Billion | ▲ +359.0% |
| 2019 | 2.78x | ₩16.99 Billion | ₩47.31 Billion | ▲ +163.9% |
| 2018 | 1.06x | ₩15.54 Billion | ₩16.40 Billion | ▲ +123.1% |
| 2017 | 0.47x | ₩20.45 Billion | ₩9.67 Billion | ▼ -31.8% |
| 2016 | 0.69x | ₩15.50 Billion | ₩10.76 Billion | ▼ -16.5% |
| 2015 | 0.83x | ₩14.34 Billion | ₩11.91 Billion | ▲ +225.1% |
| 2014 | 0.26x | ₩11.22 Billion | ₩2.87 Billion | ▼ -31.9% |
| 2013 | 0.38x | ₩10.92 Billion | ₩4.10 Billion | ▲ +56.7% |
| 2012 | 0.24x | ₩22.90 Billion | ₩5.48 Billion | ▼ -86.0% |
| 2011 | 1.70x | ₩12.96 Billion | ₩22.09 Billion | ▲ +106.2% |
| 2010 | 0.83x | ₩23.89 Billion | ₩19.74 Billion | ▲ +62.3% |
| 2009 | 0.51x | ₩26.57 Billion | ₩13.53 Billion | ▲ +56.8% |
| 2008 | 0.32x | ₩10.69 Billion | ₩3.47 Billion | — |